Cargando…

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab

Detalles Bibliográficos
Autores principales: Baraliakos, X, Listing, J, Rudwaleit, M, Brandt, J, Sieper, J, Braun, J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834030/
http://dx.doi.org/10.1186/ar1552
_version_ 1782178524257320960
author Baraliakos, X
Listing, J
Rudwaleit, M
Brandt, J
Sieper, J
Braun, J
author_facet Baraliakos, X
Listing, J
Rudwaleit, M
Brandt, J
Sieper, J
Braun, J
author_sort Baraliakos, X
collection PubMed
description
format Text
id pubmed-2834030
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28340302010-03-08 Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab Baraliakos, X Listing, J Rudwaleit, M Brandt, J Sieper, J Braun, J Arthritis Res Ther Poster Presentation BioMed Central 2005 2005-02-17 /pmc/articles/PMC2834030/ http://dx.doi.org/10.1186/ar1552 Text en Copyright ©2005 BioMed Central Ltd
spellingShingle Poster Presentation
Baraliakos, X
Listing, J
Rudwaleit, M
Brandt, J
Sieper, J
Braun, J
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title_full Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title_fullStr Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title_full_unstemmed Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title_short Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
title_sort radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834030/
http://dx.doi.org/10.1186/ar1552
work_keys_str_mv AT baraliakosx radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab
AT listingj radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab
AT rudwaleitm radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab
AT brandtj radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab
AT sieperj radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab
AT braunj radiographicprogressioninpatientswithankylosingspondylitisafter2yearsoftreatmentwiththetumornecrosisfactoralphaantibodyinfliximab